Kimberly E. Hanson

5.5k total citations · 2 hit papers
92 papers, 3.1k citations indexed

About

Kimberly E. Hanson is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Kimberly E. Hanson has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 51 papers in Epidemiology and 19 papers in Clinical Biochemistry. Recurrent topics in Kimberly E. Hanson's work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (20 papers) and Bacterial Identification and Susceptibility Testing (18 papers). Kimberly E. Hanson is often cited by papers focused on Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (20 papers) and Bacterial Identification and Susceptibility Testing (18 papers). Kimberly E. Hanson collaborates with scholars based in United States, Canada and Australia. Kimberly E. Hanson's co-authors include Emily S Spivak, Angela M. Caliendo, L. Barth Reller, Adam P. Barker, Barbara D. Alexander, Marc Roger Couturier, E. Susan Slechta, Christine C. Ginocchio, Anne J. Blaschke and Robin Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Plant Cell.

In The Last Decade

Kimberly E. Hanson

89 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Better Tests, Better Care: Improved Diagnostics for Infectious Diseases

2013 461 citations Angela M. Caliendo, David N. Gilbert et al. Clinical Infectious Diseases profile →
Candida auris: an Emerging Fungal Pathogen

2017 278 citations Kimberly E. Hanson et al. Journal of Clinical Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly E. Hanson United States	27	1.7k	1.5k	447	419	378	92	3.1k
Heungsup Sung South Korea	33	2.6k 1.5×	2.6k 1.7×	291 0.7×	622 1.5×	342 0.9×	275	5.6k
Elitza S. Theel United States	28	2.2k 1.3×	1.1k 0.8×	439 1.0×	362 0.9×	215 0.6×	110	3.6k
Koichi Izumikawa Japan	35	2.4k 1.4×	2.5k 1.7×	233 0.5×	803 1.9×	80 0.2×	353	4.8k
George Alangaden United States	34	2.5k 1.4×	2.2k 1.4×	379 0.8×	426 1.0×	78 0.2×	129	4.3k
Sebastiaan J. van Hal Australia	35	2.1k 1.2×	1.3k 0.9×	921 2.1×	574 1.4×	106 0.3×	110	3.3k
Lars F. Westblade United States	39	1.5k 0.8×	1.1k 0.7×	893 2.0×	1.6k 3.7×	297 0.8×	158	4.6k
Sharon C.‐A. Chen Australia	37	2.9k 1.7×	2.5k 1.7×	232 0.5×	312 0.7×	91 0.2×	119	3.8k
Ronen Ben‐Ami Israel	36	2.8k 1.6×	2.6k 1.7×	322 0.7×	620 1.5×	82 0.2×	158	5.4k
Luciano Zubaran Goldani Brazil	27	1.3k 0.7×	1.4k 1.0×	213 0.5×	465 1.1×	59 0.2×	125	3.2k
Silke Schelenz United Kingdom	28	2.1k 1.2×	1.6k 1.0×	171 0.4×	312 0.7×	65 0.2×	75	2.9k

Countries citing papers authored by Kimberly E. Hanson

Since Specialization

Citations

This map shows the geographic impact of Kimberly E. Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly E. Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly E. Hanson more than expected).

Fields of papers citing papers by Kimberly E. Hanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly E. Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly E. Hanson. The network helps show where Kimberly E. Hanson may publish in the future.

Co-authorship network of co-authors of Kimberly E. Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly E. Hanson. A scholar is included among the top collaborators of Kimberly E. Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly E. Hanson. Kimberly E. Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heldman, Madeleine R., et al.. (2025). Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts. Clinical Infectious Diseases. 81(5). 1008–1014. 1 indexed citations

Hanson, Kimberly E. & Ephraim L. Tsalik. (2025). Host Immune Response Profiling for the Diagnosis of Infectious Diseases. The Journal of Infectious Diseases. 232(5). 1029–1039. 1 indexed citations

Haas, Ann, Benjamin T. Bradley, & Kimberly E. Hanson. (2024). Recent Developments in Culture-Independent Fungal Diagnostics. Infectious Disease Clinics of North America. 39(1). 41–56. 1 indexed citations

Hayden, Mary K., Kimberly E. Hanson, Janet A. Englund, et al.. (2024). Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic Testing. Clinical Infectious Diseases. 13 indexed citations

Neofytos, Dionysios, William J. Steinbach, Kimberly E. Hanson, et al.. (2023). American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients. Transplantation and Cellular Therapy. 29(4). 222–227. 1 indexed citations

Hymas, Weston, Keith E. Simmon, Michael T. Pyne, et al.. (2023). Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV. Journal of Clinical Microbiology. 61(12). e0082923–e0082923. 11 indexed citations

Imlay, Hannah & Kimberly E. Hanson. (2023). Transplant-Related Infections. Infectious Disease Clinics of North America. 37(3). i–i.

Colgrove, Robert C., Lou Ann Bruno‐Murtha, Cody A. Chastain, et al.. (2022). Tale of the Titers: Serologic Testing for SARS-CoV-2—Yes, No, and Maybe, With Clinical Examples From the IDSA Diagnostics Committee. Open Forum Infectious Diseases. 10(1). ofac674–ofac674. 3 indexed citations

Langer, Janine, et al.. (2022). Characterization of the Cytopathic Effects of Monkeypox Virus Isolated from Clinical Specimens and Differentiation from Common Viral Exanthems. Journal of Clinical Microbiology. 60(12). e0133622–e0133622. 12 indexed citations

10.

Imlay, Hannah, Paul Baum, Daniel C. Brennan, et al.. (2022). Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials. Clinical Infectious Diseases. 75(7). 1210–1216. 20 indexed citations

11.

Greninger, Alexander L., Jennifer Dien Bard, Robert C. Colgrove, et al.. (2021). Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document. Journal of Clinical Microbiology. 60(1). e0165921–e0165921. 6 indexed citations

12.

Barker, Adam P., et al.. (2021). Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting. Journal of Clinical Microbiology. 59(4). 53 indexed citations

13.

Pyne, Michael T., Adam P. Barker, Jeanmarie Mayer, et al.. (2021). Efficient and effective single-step screening of individual samples for SARS-CoV-2 RNA using multi-dimensional pooling and Bayesian inference. Journal of The Royal Society Interface. 18(179). 20210155–20210155. 1 indexed citations

14.

Hanson, Kimberly E., et al.. (2020). Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2. Journal of Clinical Microbiology. 58(11). 106 indexed citations

15.

Powers‐Fletcher, Margaret V. & Kimberly E. Hanson. (2016). Nonculture Diagnostics in Fungal Disease. Infectious Disease Clinics of North America. 30(1). 37–49. 16 indexed citations

16.

Eschenauer, Gregory, M. Hong Nguyen, Shmuel Shoham, et al.. (2014). Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates. Antimicrobial Agents and Chemotherapy. 58(4). 1897–1906. 54 indexed citations

17.

Barker, Adam P., et al.. (2014). Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory. Medical Mycology. 52(5). 537–545. 20 indexed citations

18.

Caliendo, Angela M., David N. Gilbert, Christine C. Ginocchio, et al.. (2013). Better Tests, Better Care: Improved Diagnostics for Infectious Diseases. Clinical Infectious Diseases. 57(suppl 3). S139–S170. 461 indexed citations breakdown →

19.

Hobeika, Amy, Takuya Osada, Delila Serra, et al.. (2008). Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease. Cytotherapy. 10(3). 289–302. 7 indexed citations

20.

Reddy, Anita, Aimee K. Zaas, Kimberly E. Hanson, & Scott M. Palmer. (2007). A Single-center Experience With Ganciclovir-resistant Cytomegalovirus in Lung Transplant Recipients: Treatment and Outcome. The Journal of Heart and Lung Transplantation. 26(12). 1286–1292. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact